Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology.
作者信息
HILLEMAN M R, STALLONES R A, GAULD R L, WARFIELD M S, ANDERSON S A
出版信息
Am J Public Health Nations Health. 1957 Jul;47(7):841-7. doi: 10.2105/ajph.47.7.841.
Abstract
摘要
相似文献
1
Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology.针对腺病毒引起的急性呼吸道疾病（RI-APC-ARD）的疫苗接种。
Am J Public Health Nations Health. 1957 Jul;47(7):841-7. doi: 10.2105/ajph.47.7.841.
2
Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development.用于预防急性呼吸道疾病的腺病毒（RI-APC-ARD）疫苗。I. 疫苗研发。
J Am Med Assoc. 1957 Jan 5;163(1):4-15. doi: 10.1001/jama.1957.02970360006002.
3
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine.腺病毒（RI-APC-ARD）疫苗预防新兵急性呼吸道疾病
Proc Soc Exp Biol Med. 1956 Jun;92(2):377-83. doi: 10.3181/00379727-92-22484.
4
Efficacy of trivalent adenovirus (APC) vaccine in naval recruits.三价腺病毒（APC）疫苗在海军新兵中的效力。
J Am Med Assoc. 1956 Aug 18;161(16):1521-5. doi: 10.1001/jama.1956.02970160001001.
5
Electron microscopy of HeLa cells infected with agents of the adenovirus (APC-RI-ARD) group.感染腺病毒（APC-RI-ARD）组病原体的HeLa细胞的电子显微镜检查。
Arch Gesamte Virusforsch. 1957;7(3):221-41. doi: 10.1007/BF01240877.
6
[Clinical aspects of viral respiratory infections].[病毒性呼吸道感染的临床方面]
Minerva Med. 1980 Dec 8;71(49):3599-605.
7
Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents).
Am J Med. 1956 Aug;21(2):161-74. doi: 10.1016/0002-9343(56)90049-3.
8
Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination.军事训练学员中腺病毒4型急性呼吸道疾病的再次出现：疫苗接种中断期间的一次暴发报告
J Infect Dis. 1999 Jun;179(6):1531-3. doi: 10.1086/314772.
9
Mass enteric live adenovirus vaccination during epidemic ARD.在流行性急性呼吸道疾病期间进行大规模肠道活腺病毒疫苗接种。
JAMA. 1968 Jul 1;205(1):75-80. doi: 10.1001/jama.205.1.75.
10
Some recent trends in vaccination against respiratory viruses.近期呼吸道病毒疫苗接种的一些趋势。
Br Med Bull. 1969 May;25(2):165-71. doi: 10.1093/oxfordjournals.bmb.a070687.
引用本文的文献
1
2
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.黏膜疫苗、灭菌免疫与SARS-CoV-2毒力的未来
Viruses. 2022 Jan 19;14(2):187. doi: 10.3390/v14020187.
3
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.胃肠道 SARS-CoV-2 递呈对恒河猴鼻内和气管内 SARS-CoV-2 挑战的保护效力。
J Virol. 2022 Jan 26;96(2):e0159921. doi: 10.1128/JVI.01599-21. Epub 2021 Oct 27.
4
Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.口服4型和7型腺病毒活疫苗可诱导持久的抗体反应。
Vaccines (Basel). 2020 Jul 23;8(3):411. doi: 10.3390/vaccines8030411.
5
Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.应用基因组和生物信息资源于人类腺病毒基因组，用于疫苗开发，并应用于基因传递载体的开发。
Viruses. 2010 Jan;2(1):1-26. doi: 10.3390/v2010001. Epub 2010 Jan 6.
6
Broad spectrum respiratory pathogen analysis of throat swabs from military recruits reveals interference between rhinoviruses and adenoviruses.对新兵咽喉拭子进行的广谱呼吸道病原体分析显示，鼻病毒和腺病毒之间存在干扰。
Microb Ecol. 2010 May;59(4):623-34. doi: 10.1007/s00248-010-9636-3. Epub 2010 Mar 9.
7
Viruses of diseases of the respiratory tract.呼吸道疾病病毒。
Br Med J. 1962 Oct 6;2(5309):869-78. doi: 10.1136/bmj.2.5309.869.
本文引用的文献
1
Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations.新兵群体中RI（RI-67）组呼吸道病毒感染的流行病学
Am J Hyg. 1955 Jul;62(1):29-42. doi: 10.1093/oxfordjournals.aje.a119764.
2
Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD).RI - 67病原体与急性呼吸道疾病（ARD）的病因学关系。
J Clin Invest. 1955 Jun;34(6):820-31. doi: 10.1172/JCI103137.
3
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine.腺病毒（RI-APC-ARD）疫苗预防新兵急性呼吸道疾病
Proc Soc Exp Biol Med. 1956 Jun;92(2):377-83. doi: 10.3181/00379727-92-22484.
4
Efficacy of trivalent adenovirus (APC) vaccine in naval recruits.三价腺病毒（APC）疫苗在海军新兵中的效力。
J Am Med Assoc. 1956 Aug 18;161(16):1521-5. doi: 10.1001/jama.1956.02970160001001.
5
Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents).
Am J Med. 1956 Aug;21(2):161-74. doi: 10.1016/0002-9343(56)90049-3.
6
Clinical diseases of adults associated with sporadic infections by APC viruses.与腺病毒科病毒散发性感染相关的成人临床疾病。
AMA Arch Intern Med. 1956 Jul;98(1):71-9. doi: 10.1001/archinte.1956.00250250077010.
7
Adenoviruses: group name proposed for new respiratory-tract viruses.腺病毒：为新型呼吸道病毒提议的类别名称。
Science. 1956 Jul 20;124(3212):119-20. doi: 10.1126/science.124.3212.119.
8
Additional serotypes of the APC virus group.APC病毒组的其他血清型。
Proc Soc Exp Biol Med. 1956 Feb;91(2):260-2. doi: 10.3181/00379727-91-22231.
9
Grouping and occurrence of RI (prototype RI-67) viruses.RI（原型RI - 67）病毒的分组与出现情况。
Proc Soc Exp Biol Med. 1955 Dec;90(3):555-62. doi: 10.3181/00379727-90-22097.
10
new type of APC virus from epidemic keratoconjunctivitis.来自流行性角结膜炎的新型腺病毒科病毒
Science. 1955 Dec 16;122(3181):1190-1. doi: 10.1126/science.122.3181.1190-a.
Zotero 插件